David C. Shelton Sells 19,000 Shares of Chemours Company (The) (CC) Stock

Chemours Company (The) (NYSE:CC) SVP David C. Shelton sold 19,000 shares of the firm’s stock in a transaction dated Thursday, October 5th. The stock was sold at an average price of $53.68, for a total transaction of $1,019,920.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

David C. Shelton also recently made the following trade(s):

  • On Thursday, August 31st, David C. Shelton sold 13,337 shares of Chemours Company (The) stock. The stock was sold at an average price of $48.48, for a total transaction of $646,577.76.

Chemours Company (NYSE CC) opened at 57.01 on Tuesday. The company has a market cap of $10.54 billion, a price-to-earnings ratio of 37.31 and a beta of 3.60. The company’s 50-day moving average is $51.25 and its 200 day moving average is $44.05. Chemours Company has a 1-year low of $14.73 and a 1-year high of $57.08.

Chemours Company (The) (NYSE:CC) last released its earnings results on Wednesday, August 2nd. The specialty chemicals company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. The business had revenue of $1.59 billion during the quarter, compared to the consensus estimate of $1.49 billion. Chemours Company (The) had a net margin of 4.96% and a return on equity of 122.97%. The company’s revenue for the quarter was up 14.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.27 EPS. On average, equities analysts predict that Chemours Company will post $3.54 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: This piece was first posted by BBNS and is the sole property of of BBNS. If you are reading this piece on another website, it was copied illegally and reposted in violation of United States & international trademark & copyright law. The original version of this piece can be accessed at https://baseballnewssource.com/markets/chemours-company-the-cc-svp-sells-1019920-00-in-stock/1697703.html.

Several institutional investors have recently bought and sold shares of the business. Financial Architects Inc lifted its holdings in shares of Chemours Company (The) by 1,230.3% in the 2nd quarter. Financial Architects Inc now owns 2,940 shares of the specialty chemicals company’s stock worth $111,000 after purchasing an additional 2,719 shares in the last quarter. Acrospire Investment Management LLC lifted its holdings in shares of Chemours Company (The) by 3.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 3,076 shares of the specialty chemicals company’s stock worth $117,000 after purchasing an additional 100 shares in the last quarter. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Chemours Company (The) by 2,138.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 3,112 shares of the specialty chemicals company’s stock worth $118,000 after purchasing an additional 2,973 shares in the last quarter. Schroder Investment Management Group bought a new position in shares of Chemours Company (The) in the 1st quarter worth $156,000. Finally, Smithfield Trust Co. lifted its holdings in shares of Chemours Company (The) by 521.4% in the 2nd quarter. Smithfield Trust Co. now owns 4,791 shares of the specialty chemicals company’s stock worth $182,000 after purchasing an additional 4,020 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

A number of equities research analysts recently issued reports on CC shares. BidaskClub cut shares of Chemours Company (The) from a “buy” rating to a “hold” rating in a research report on Friday, August 11th. Zacks Investment Research upgraded shares of Chemours Company (The) from a “hold” rating to a “strong-buy” rating and set a $51.00 price objective for the company in a research report on Friday, July 14th. Citigroup Inc. upgraded shares of Chemours Company (The) from a “neutral” rating to a “buy” rating and raised their price objective for the company from $43.00 to $45.00 in a research report on Wednesday, July 5th. Jefferies Group LLC raised their price objective on shares of Chemours Company (The) to $60.00 and gave the company a “buy” rating in a research report on Thursday, August 3rd. Finally, Argus restated a “buy” rating and issued a $55.00 price objective (up previously from $50.00) on shares of Chemours Company (The) in a research report on Thursday, August 10th. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $52.75.

About Chemours Company (The)

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Insider Buying and Selling by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1


Leave a Reply

 
© 2006-2017 BBNS.